Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, an Neurohumoral Activation

Circulation

Volumn 109, Issue 18, 2004, Pages 2227-2233

  Hilfiker Kleiner, Denise ^a   Kaminski, Karol ^b   Kaminska, Agnieszka ^a   Fuchs, Martin ^a   Klein, Gunnar ^a   Podewski, Edith ^a   Grote, Karsten ^a   Kiian, Ioulia ^a   Wollert, Kai C ^a   Hilfiker, Andres ^a   Drexler, Helmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Angiogenesis; Ischemia; Myocardial infarction; Pressure; Signal transduction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CYSTEINE RICH PROTEIN 61; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROHORMONE; NEUTRALIZING ANTIBODY; PHENYLEPHRINE; PROTEIN KINASE C;

ADAPTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MALE; MOUSE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STRESS; TISSUE INJURY;

ALKALOIDS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BENZOPHENANTHRIDINES; CELL MOVEMENT; CELLS, CULTURED; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NAPHTHALENES; NEOVASCULARIZATION, PHYSIOLOGIC; NOREPINEPHRINE; PARACRINE COMMUNICATION; PHENANTHRIDINES; PHENYLEPHRINE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; STRESS, MECHANICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442503516     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000127952.90508.9D     Document Type: Article

References (21)

1. Kim CH, Cho YS, Chun YS, et al. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res. 2002;90:E25-E33.
2. Li J, Hampton T, Morgan JP, et al. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100:18-24.
3. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation. 2003;107:1359-1365.
4. Freedman SB, Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med. 2002;136:54-71.
5. Brigstock DR, Goldschmeding R, Katsube KI, et al. Proposal for a unified CCN nomenclature. Mol Pathol. 2003;56:127-128.
6. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831-840.
7. Fataccioli V, Abergel V, Wingertsmann L, et al. Stimulation of angiogenesis by cyr61 gene: a new therapeutic candidate. Hum Gene Ther. 2002;13:1461-1470.
8. Schober JM, Chen N, Grzeszkiewicz TM, et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood. 2002;99:4457-4465.
9. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol. 2001;54:57-79.
10. Babic AM, Kireeva ML, Kolesnikova TV, et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A. 1998;95:6355-6360.
11. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, et al. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation. 2002;106:254-260.
12. Korte T, Fuchs M, Guener Z, et al. In-vivo electrophysiological study in mice with chronic anterior myocardial infarction. J Interv Card Electrophysiol. 2002;6:121-132.
13. Rockmah HA, Ross RS, Harris AN, et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo mutrine model of cardiac hypertrophy. Proc Natl Acad Sci U S A. 1991;88:8277-8281.
14. Hilfiker-Kleiner D, Hilfiker A, Schieffer B, et al. TNFalpha decreases alphaMHC expression by a NO mediated pathway: role of E-box transcription factors for cardiomyocyte specific gene regulation. Cardiovasc Res. 2002;53:460-469.
15. Kiian I, Tkachuk N, Haller H, et al. Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway. Thromb Haemost. 2003;89:904-914.
16. Clerk A, Sugden PH. Untangling the web: specific signaling from PKC isoforms to MAPK cascades. Circ Res. 2001;89:847-849.
17. Dor Y, Camenisch TD, Itin A, et al. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development. 2001;128:1531-1538.
18. Kodama H, Fukuda K, Pan J, et al. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am J Physiol. 2000;279:H1635-H1644.
19. Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
20. Leu SJ, Lam SC, Lau LF. Pro-angiogenic activities of CYR61 (CCNI) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical. vein endothelial cells. J Biol Chem. 2002;277:46248-46255.
21. Chen CC, Mo FE, Lau LF. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem. 2001;276:47329-47337.